Insider · CIK 0001250318

YACHMETZ PHILIP K

Reports to the SEC for 3 companies · EAST BRUNSWICK, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001250318

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-07-16	Teligent, Inc.M Exercise/Conversion	EVP, Chief Legal Off, Corp Sec	MExercise/Conversion	+7,835 sh	—	—	7,835
2021-07-16	Teligent, Inc.M Exercise/Conversion	EVP, Chief Legal Off, Corp Sec	MExercise/Conversion	+7,835 sh	—	—	7,835
2021-07-16	Teligent, Inc.F Tax Payment	EVP, Chief Legal Off, Corp Sec	FTax Payment	−2,656 sh	$0.47	−$1,248.32	5,179
2021-07-16	Teligent, Inc.Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Legal Off, Corp Sec	MExercise/Conversion	+7,835 sh	—	—	15,670
2021-07-16	Teligent, Inc.F Tax Payment	EVP, Chief Legal Off, Corp Sec	FTax Payment	−2,656 sh	$0.47	−$1,248.32	5,176
2021-07-16	Teligent, Inc.Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Legal Off, Corp Sec	MExercise/Conversion	+7,835 sh	—	—	15,670
2021-03-11	Teligent, Inc.Stock OptionA Award	EVP, Chief Legal Off, Corp Sec	AAward	+424K sh	—	—	424,000
2021-03-11	Teligent, Inc.Restricted Stock UnitsA Award	EVP, Chief Legal Off, Corp Sec	AAward	+344K sh	—	—	344,400
2020-07-16	Teligent, Inc.Stock OptionA Award	EVP, Chief Legal Off, Corp Sec	AAward	+36.3K sh	—	—	36,325
2020-07-16	Teligent, Inc.Restricted Stock UnitsA Award	EVP, Chief Legal Off, Corp Sec	AAward	+23.5K sh	—	—	23,505
2013-10-15	SAVIENT PHARMACEUTICALS INCS Sale	Co-President and CBO	SSale	−20K sh	$0.10	−$2,030	283,701
2013-10-15	SAVIENT PHARMACEUTICALS INCS Sale	Co-President and CBO	SSale	−19.7K sh	$0.10	−$1,921.189	263,956
2013-10-15	SAVIENT PHARMACEUTICALS INCS Sale	Co-President and CBO	SSale	−20K sh	$0.09	−$1,828	243,956
2013-10-15	SAVIENT PHARMACEUTICALS INCS Sale	Co-President and CBO	SSale	−40K sh	$0.10	−$4,000	203,956
2013-10-15	SAVIENT PHARMACEUTICALS INCS Sale	Co-President and CBO	SSale	−50K sh	$0.10	−$4,895	153,956
2013-10-15	SAVIENT PHARMACEUTICALS INCS Sale	Co-President and CBO	SSale	−53.4K sh	$0.10	−$5,244.96	100,545
2013-10-15	SAVIENT PHARMACEUTICALS INCS Sale	Co-President and CBO	SSale	−10K sh	$0.09	−$916	90,545
2013-03-05	SAVIENT PHARMACEUTICALS INCOption to Purchase Common StockA Award	Co-President and CBO	AAward	+110K sh	—	—	110,000
2013-03-05	SAVIENT PHARMACEUTICALS INCOption to Purchase Common StockA Award	Co-President and CBO	AAward	+78K sh	—	—	78,000
2013-02-04	SAVIENT PHARMACEUTICALS INCS Sale	Co-President and CBO	SSale	−27.3K sh	$1.01	−$27.6K	306,904
2013-02-04	SAVIENT PHARMACEUTICALS INCS Sale	Co-President and CBO	SSale	−3,203 sh	$1.02	−$3,267.06	303,701
2013-01-14	SAVIENT PHARMACEUTICALS INCS Sale	Co-President and CBO	SSale	−1,283 sh	$1.14	−$1,462.62	334,201
2012-02-27	SAVIENT PHARMACEUTICALS INCA Award	Co-President and CBO	AAward	+100K sh	$2.10	+$210K	335,484
2012-02-14	SAVIENT PHARMACEUTICALS INCS Sale	Co-President and CBO	SSale	−3,540 sh	$2.02	−$7,150.8	235,484
2012-02-01	SAVIENT PHARMACEUTICALS INCA Award	Co-President and CBO	AAward	+50K sh	$2.26	+$113K	239,024
2012-02-01	SAVIENT PHARMACEUTICALS INCOption to Purchase Common Stock, $01 par valueA Award	Co-President and CBO	AAward	+100K sh	$2.26	+$226K	100,000
2011-09-16	SAVIENT PHARMACEUTICALS INCP Purchase	Co-President and CBO	PPurchase	+7,000 sh	$4.13	+$28.9K	189,024
2011-02-14	SAVIENT PHARMACEUTICALS INCS Sale	Co-President and CBO	SSale	−3,210 sh	$9.88	−$31.7K	182,024
2010-09-16	SAVIENT PHARMACEUTICALS INCA Award	Co-President and CBO	AAward	+22.9K sh	$20.27	+$465K	193,352
2010-09-16	SAVIENT PHARMACEUTICALS INCF Tax Payment	Co-President and CBO	FTax Payment	−8,118 sh	$20.27	−$165K	185,234
2010-02-16	SAVIENT PHARMACEUTICALS INCS Sale	Co-President and CBO	SSale	−2,471 sh	$13.80	−$34.1K	170,434
2010-02-16	SAVIENT PHARMACEUTICALS INCS Sale	Co-President and CBO	SSale	−3,307 sh	$13.79	−$45.6K	167,127
2009-12-09	SAVIENT PHARMACEUTICALS INCS Sale	Co-President and CBO	SSale	−5,418 sh	$13.31	−$72.1K	172,905
2009-02-19	SAVIENT PHARMACEUTICALS INCOption to Purchase Common Stock, $.01 par valueM Exercise/Conversion	Co-President and CBO	MExercise/Conversion	+50K sh	$5.27	+$264K	50,000
2009-02-19	SAVIENT PHARMACEUTICALS INCOption to Purchase Common Stock, $.01 par valueM Exercise/Conversion	Co-President and CBO	MExercise/Conversion	+15K sh	$8.27	+$124K	65,000
2009-02-19	SAVIENT PHARMACEUTICALS INCOption to Purchase Common Stock, $.01 par valueM Exercise/Conversion	Co-President and CBO	MExercise/Conversion	+50K sh	$5.27	+$264K	50,000
2009-02-19	SAVIENT PHARMACEUTICALS INCOption to Purchase Common Stock, $.01 par valueM Exercise/Conversion	Co-President and CBO	MExercise/Conversion	+15K sh	$8.27	+$124K	65,000
2009-02-17	SAVIENT PHARMACEUTICALS INCS Sale	Co-President and CBO	SSale	−5,868 sh	$5.73	−$33.6K	185,823
2009-02-17	SAVIENT PHARMACEUTICALS INCS Sale	Co-President and CBO	SSale	−5,868 sh	$5.73	−$33.6K	185,823
2009-02-13	SAVIENT PHARMACEUTICALS INCA Award	Co-President and CBO	AAward	−25K sh	$5.94	−$149K	191,691
2009-02-13	SAVIENT PHARMACEUTICALS INCA Award	Co-President and CBO	AAward	+25K sh	$5.94	+$149K	191,691
2008-01-04	SAVIENT PHARMACEUTICALS INCM Exercise/Conversion	Co-President and CBO	MExercise/Conversion	+5,000 sh	$2.78	+$13.9K	148,087
2008-01-04	SAVIENT PHARMACEUTICALS INCS Sale	Co-President and CBO	SSale	−5,000 sh	$23.27	−$116K	143,087
2008-01-04	SAVIENT PHARMACEUTICALS INCOption to Purchase Common Stock, $.01 par valueM Exercise/Conversion	Co-President and CBO	MExercise/Conversion	−5,000 sh	$2.78	−$13.9K	16,250
2008-01-03	SAVIENT PHARMACEUTICALS INCM Exercise/Conversion	Co-President and CBO	MExercise/Conversion	+1,250 sh	$2.42	+$3,025	144,337
2008-01-03	SAVIENT PHARMACEUTICALS INCM Exercise/Conversion	Co-President and CBO	MExercise/Conversion	+3,750 sh	$2.78	+$10.4K	148,087
2008-01-03	SAVIENT PHARMACEUTICALS INCS Sale	Co-President and CBO	SSale	−5,000 sh	$24.26	−$121K	143,087
2008-01-03	SAVIENT PHARMACEUTICALS INCOption to Purchase Common Stock, $.01 par valueM Exercise/Conversion	Co-President and CBO	MExercise/Conversion	−1,250 sh	$2.42	−$3,025	78,750
2008-01-03	SAVIENT PHARMACEUTICALS INCOption to Purchase Common Stock, $.01 par valueM Exercise/Conversion	Co-President and CBO	MExercise/Conversion	−3,750 sh	$2.78	−$10.4K	21,250
2008-01-02	SAVIENT PHARMACEUTICALS INCM Exercise/Conversion	Co-President and CBO	MExercise/Conversion	+5,000 sh	$2.42	+$12.1K	148,087

Recent filings

Accepted (ET)
Jul 204/A
YACHMETZ PHILIP K0000352998-21-000008
SEC(opens sec.gov)
Jul 204
YACHMETZ PHILIP K0000352998-21-000007
SEC(opens sec.gov)
Mar 154
YACHMETZ PHILIP K0001104659-21-036284
SEC(opens sec.gov)
Jul 174
YACHMETZ PHILIP K0001104659-20-084510
SEC(opens sec.gov)
Oct 174
SAVIENT PHARMACEUTICALS INC0001181431-13-054179
SEC(opens sec.gov)
Mar 74
YACHMETZ PHILIP K0001181431-13-015379
SEC(opens sec.gov)
Feb 64
YACHMETZ PHILIP K0001181431-13-007054
SEC(opens sec.gov)

Companies

Address

SAVIENT PHARMACEUTICALS, INC. ONE TOWER CENTER, 14TH FLOOR

EAST BRUNSWICK, NJ, 08816